A Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Chinese Healthy Adults
NCT05275660
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
HFB30132A
OTHER:
Placebo
Sponsor
HiFiBiO Therapeutics